stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

abrdn World Healthcare Fund

United States · NYSE: THW · Market cap: · P/E: · P/S:

A closed-end fund that invests in healthcare company stocks and bonds to generate income and capital growth for shareholders.

abrdn World Healthcare Fund is a closed-end fund, which is a type of pooled investment vehicle that raises money once from investors and then trades on an exchange like a regular stock. The fund invests that money in a portfolio of healthcare companies around the world, mostly by buying their stocks but also by buying their debt. An investor buys shares to get exposure to the healthcare industry — everything from drugmakers and medical device manufacturers to hospitals and insurers — without having to pick individual companies.

The fund's goal is twofold: it wants to pay shareholders regular income, largely by collecting dividends from the stocks it owns and interest from the bonds, and it also wants the portfolio to grow in value over time through capital appreciation. This is a common structure for closed-end funds, which differ from mutual funds in that they issue a fixed number of shares that then trade on the open market. The share price can trade above or below the value of the underlying assets, a quirk that creates both opportunity and risk for buyers. The fund is managed by abrdn, a large global asset manager, and it was formerly known as the Tekla World Healthcare Fund before rebranding. Its shares are listed on the New York Stock Exchange, which means investors can buy and sell them through a regular brokerage account throughout the trading day. The fund charges management fees for running the portfolio, and like many closed-end funds it has historically used leverage — borrowing money to invest more than it raises from shareholders — which can amplify both gains and losses.


Healthcare is a sector with strong long-term tailwinds: aging populations, rising medical spending, and constant innovation in drugs and devices. But it also faces real headwinds: political pressure on drug pricing, regulatory changes, and the risk that a small number of expensive bets on new medicines fail. For an investor who wants a diversified, professionally managed slice of the healthcare world and a steady income stream, a fund like this offers a simple way in — provided they understand the leverage, the fees, and the fact that the market price of the shares can drift away from the value of the underlying portfolio.

Saved answer · last researched 16 Nov 2026